{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:30:32Z","timestamp":1786480232665,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2025,4]]},"abstract":"\n Key Points<\/jats:title>\n \n \n \n Multiple assays are available to measure calciprotein particles (CPP), but a direct comparison of their association with clinical outcomes is lacking.<\/jats:p>\n <\/jats:list-item>\n \n Higher levels of high-density CPP and secondary CPP were independently associated with all-cause mortality in a CKD cohort.<\/jats:p>\n <\/jats:list-item>\n \n Higher levels of low-density CPP, primary CPP, and secondary CPP were each independently associated with progression of CKD.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n Mineral metabolism abnormalities are an almost universal feature of CKD and are believed to contribute to the development of many adverse events. Calciprotein particles (CPP) form spontaneously in biological fluids from calcium and phosphate together with the glycoprotein fetuin-A. While CPP formation is a part of normal mineral homeostasis, levels are chronically elevated in CKD. Several assays have been developed to measure serum CPP, each linking high CPP levels to adverse clinical outcomes in CKD. However, direct comparisons among these assays are lacking. The aim of this exploratory study was to compare these assays to assess their association with CKD progression and mortality.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n We measured baseline CPP levels using various methods on stored serum samples from 189 participants in a prospective observational cohort study of patients with CKD stage 3\/4. Three assays were used to measure CPP: (\n 1<\/jats:italic>\n ) ELISA (fetuin-A CPP), (\n 2<\/jats:italic>\n ) low-density CPP (L-CPP) and high-density CPP by gel filtration, and (\n 3<\/jats:italic>\n ) primary CPP and secondary CPP (CPP-II) by flow cytometry. We examined the association of each CPP measure with all-cause mortality and CKD progression using unadjusted and covariate-adjusted Cox proportional hazard regression models.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n In fully adjusted models, high-density CPP (hazard ratio [HR], 1.53; 95% confidence interval [CI], 1.05 to 2.23;\n P<\/jats:italic>\n = 0.028) and CPP-II (HR, 3.11; 95% CI, 1.97 to 4.98;\n P<\/jats:italic>\n < 0.001) were significantly associated with an increased risk of all-cause mortality. In addition, L-CPP (HR, 1.91; 95% CI, 1.43 to 2.62;\n P<\/jats:italic>\n < 0.001), primary CPP (HR, 1.31; 95% CI, 1.04 to 1.65;\n P<\/jats:italic>\n = 0.023), and CPP-II (HR, 1.66; 95% CI, 1.20 to 2.29;\n P<\/jats:italic>\n = 0.002) were significantly associated with CKD progression.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n In a cohort of patients with CKD stages 3 and 4, serum CPP-II levels demonstrated the strongest association with all-cause mortality, while L-CPP levels showed the strongest association with CKD progression.<\/jats:p>\n <\/jats:sec>","DOI":"10.34067\/kid.0000000700","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T12:00:27Z","timestamp":1737028827000},"page":"550-560","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Simultaneous Measurement of Calciprotein Particles with Different Assays and Clinical Outcomes in CKD"],"prefix":"10.34067","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9348-4638","authenticated-orcid":false,"given":"Mark K.","family":"Tiong","sequence":"first","affiliation":[{"name":"Department of Nephrology, The Royal Melbourne Hospital, Parkville, Victoria, Australia"},{"name":"Department of Medicine (RMH), University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-5539","authenticated-orcid":false,"given":"Stephen G.","family":"Holt","sequence":"additional","affiliation":[{"name":"SEHA Kidney Care, Abu Dhabi Health Services Company, Abu Dhabi, United Arab Emirates"},{"name":"Khalifa University, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4926-3189","authenticated-orcid":false,"given":"Martin L.","family":"Ford","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom"},{"name":"Faculty of Life Sciences and Medicine, Kings College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward R.","family":"Smith","sequence":"additional","affiliation":[{"name":"SEHA Kidney Care, Abu Dhabi Health Services Company, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"issue":"12","key":"B1-20250609","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"issue":"2","key":"B2-20250609","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.ajkd.2019.07.022","article-title":"Longitudinal evolution of markers of mineral metabolism in patients with CKD: the chronic renal insufficiency cohort (CRIC) study","volume":"75","author":"Isakova","year":"2020","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B3-20250609","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl (2011)."},{"issue":"14","key":"B4-20250609","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic kidney disease and coronary artery disease: JACC state-of-the-art review","volume":"74","author":"Sarnak","year":"2019","journal-title":"J Am Coll Cardiol."},{"issue":"12","key":"B5-20250609","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1016\/j.bpj.2010.10.030","article-title":"Fetuin-A is a mineral carrier protein: small angle neutron scattering provides new insight on Fetuin-A controlled calcification inhibition","volume":"99","author":"Heiss","year":"2010","journal-title":"Biophys J."},{"issue":"34","key":"B6-20250609","doi-asserted-by":"crossref","first-page":"20789","DOI":"10.1074\/jbc.271.34.20789","article-title":"The serum protein alpha2-HS glycoprotein\/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis","volume":"271","author":"Schinke","year":"1996","journal-title":"J Biol Chem."},{"issue":"15","key":"B7-20250609","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1074\/jbc.M210868200","article-title":"Structural basis of calcification inhibition by alpha 2-HS glycoprotein\/fetuin-A. Formation of colloidal calciprotein particles","volume":"278","author":"Heiss","year":"2003","journal-title":"J Biol Chem."},{"issue":"4","key":"B8-20250609","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MNH.0000000000000609","article-title":"Calciprotein particles: mineral behaving badly?","volume":"29","author":"Smith","year":"2020","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"1","key":"B9-20250609","doi-asserted-by":"crossref","first-page":"7358","DOI":"10.1038\/s41598-022-11065-3","article-title":"Effect of nutritional calcium and phosphate loading on calciprotein particle kinetics in adults with normal and impaired kidney function","volume":"12","author":"Tiong","year":"2022","journal-title":"Sci Rep."},{"issue":"5","key":"B10-20250609","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/ndt\/gfr609","article-title":"Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD","volume":"27","author":"Smith","year":"2012","journal-title":"Nephrol Dial Transplant."},{"issue":"2","key":"B11-20250609","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1681\/ASN.2013060635","article-title":"Serum calcification propensity predicts all-cause mortality in predialysis CKD","volume":"25","author":"Smith","year":"2014","journal-title":"J Am Soc Nephrol."},{"issue":"11","key":"B12-20250609","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1681\/ASN.2009090944","article-title":"Fetuin-mineral complex reflects extraosseous calcification stress in CKD","volume":"21","author":"Hamano","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B13-20250609","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1038\/s41598-017-05474-y","article-title":"A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum","volume":"7","author":"Smith","year":"2017","journal-title":"Sci Rep."},{"issue":"3","key":"B14-20250609","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/nep.12021","article-title":"Serum fetuin-A concentration and fetuin-A-containing calciprotein particles in patients with chronic inflammatory disease and renal failure","volume":"18","author":"Smith","year":"2013","journal-title":"Nephrology (Carlton)."},{"issue":"1","key":"B15-20250609","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41598-018-19677-4","article-title":"Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease","volume":"8","author":"Miura","year":"2018","journal-title":"Sci Rep."},{"key":"B16-20250609","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bone.2018.02.023","article-title":"Biochemical transformation of calciprotein particles in uraemia","volume":"110","author":"Smith","year":"2018","journal-title":"Bone."},{"issue":"5","key":"B17-20250609","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/ndt\/gfac271","article-title":"Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells","volume":"38","author":"Thiem","year":"2023","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B18-20250609","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00223-022-01036-1","article-title":"Calciprotein particle synthesis strategy determines in vitro calcification potential","volume":"112","author":"Zeper","year":"2023","journal-title":"Calcif Tissue Int."},{"issue":"5","key":"B19-20250609","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jjcc.2019.04.008","article-title":"Association of calciprotein particles measured by a new method with coronary artery plaque in patients with coronary artery disease: a cross-sectional study","volume":"74","author":"Nakazato","year":"2019","journal-title":"J Cardiol."},{"key":"B20-20250609","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2020.03.016","article-title":"Mid-term predictive value of calciprotein particles in maintenance hemodialysis patients based on a gel-filtration assay","volume":"303","author":"Gatate","year":"2020","journal-title":"Atherosclerosis."},{"issue":"4","key":"B21-20250609","doi-asserted-by":"crossref","first-page":"e60904","DOI":"10.1371\/journal.pone.0060904","article-title":"Fetuin-A-containing calciprotein particles reduce mineral stress in the macrophage","volume":"8","author":"Smith","year":"2013","journal-title":"PLoS One."},{"key":"B22-20250609","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2016.05.044","article-title":"Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-\u03b1","volume":"251","author":"Aghagolzadeh","year":"2016","journal-title":"Atherosclerosis."},{"issue":"6","key":"B23-20250609","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00223-017-0313-0","article-title":"The role of secondary calciprotein particles in the mineralisation paradox of chronic kidney disease","volume":"101","author":"Cai","year":"2017","journal-title":"Calcif Tissue Int."},{"issue":"1","key":"B24-20250609","doi-asserted-by":"crossref","first-page":"15026","DOI":"10.1038\/s41598-023-42273-0","article-title":"Removal of calciprotein particles from the blood using an adsorption column improves prognosis of hemodialysis miniature pigs","volume":"13","author":"Miura","year":"2023","journal-title":"Sci Rep."},{"key":"B25-20250609","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2020.04.017","article-title":"Calciprotein particles: a mineral biomarker in need of better measurement","volume":"303","author":"Smith","year":"2020","journal-title":"Atherosclerosis."},{"issue":"3","key":"B26-20250609","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1681\/ASN.0000000000000291","article-title":"Phosphate restriction prevents metabolic acidosis and curbs rise in FGF23 and mortality in murine folic acid-induced AKI","volume":"35","author":"Hamid","year":"2024","journal-title":"J Am Soc Nephrol."},{"issue":"9","key":"B27-20250609","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ekir.2020.06.014","article-title":"Effect of sevelamer on calciprotein particles in hemodialysis patients: the sevelamer versus calcium to reduce fetuin-A-containing calciprotein particles in dialysis (SCaRF) randomized controlled trial","volume":"5","author":"Smith","year":"2020","journal-title":"Kidney Int Rep."},{"issue":"5","key":"B28-20250609","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCRESAHA.111.261479","article-title":"Clearance of fetuin-A--containing calciprotein particles is mediated by scavenger receptor-A","volume":"111","author":"Herrmann","year":"2012","journal-title":"Circ Res."},{"key":"B29-20250609","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3389\/fimmu.2018.01991","article-title":"Cellular clearance and biological activity of calciprotein particles depend on their maturation state and crystallinity","volume":"9","author":"Koppert","year":"2018","journal-title":"Front Immunol."},{"issue":"1011","key":"B30-20250609","doi-asserted-by":"crossref","first-page":"633925","DOI":"10.3389\/fcell.2021.633925","article-title":"Live imaging of calciprotein particle clearance and receptor mediated uptake: role of calciprotein monomers","volume":"9","author":"Koeppert","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"4","key":"B31-20250609","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","article-title":"Association of disorders in mineral metabolism with progression of chronic kidney disease","volume":"1","author":"Schwarz","year":"2006","journal-title":"Clin J Am Soc Nephrol."},{"issue":"15","key":"B32-20250609","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA."},{"issue":"11-12","key":"B33-20250609","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1159\/000526609","article-title":"Serum calciprotein monomers and chronic kidney disease progression","volume":"53","author":"Tiong","year":"2022","journal-title":"Am J Nephrol."},{"issue":"4","key":"B34-20250609","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.kint.2019.10.019","article-title":"Calciprotein particles regulate fibroblast growth factor-23 expression in osteoblasts","volume":"97","author":"Akiyama","year":"2020","journal-title":"Kidney Int."},{"issue":"6","key":"B35-20250609","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7861\/clinmedicine.5-6-635","article-title":"Identification, management and referral of adults with chronic kidney disease: concise guidelines","volume":"5","author":"Burden","year":"2005","journal-title":"Clin Med (Lond)."},{"issue":"24","key":"B36-20250609","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA."},{"issue":"1","key":"B37-20250609","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw."},{"issue":"22","key":"B38-20250609","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.3390\/ijms20225728","article-title":"Calcium phosphate bions cause intimal hyperplasia in intact aortas of normolipidemic rats through endothelial injury","volume":"20","author":"Shishkova","year":"2019","journal-title":"Int J Mol Sci."},{"issue":"22","key":"B39-20250609","doi-asserted-by":"crossref","first-page":"12458","DOI":"10.3390\/ijms222212458","article-title":"Calciprotein particles link disturbed mineral homeostasis with cardiovascular disease by causing endothelial dysfunction and vascular inflammation","volume":"22","author":"Shishkova","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"16","key":"B40-20250609","doi-asserted-by":"crossref","first-page":"e145693","DOI":"10.1172\/JCI145693","article-title":"Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression","volume":"131","author":"Shiizaki","year":"2021","journal-title":"J Clin Invest."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:59:03Z","timestamp":1786478343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000700","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"2024-09-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}